Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Eli Lilly diabetes drug Mounjaro will be in focus when the drugmaker reports earnings next week
02:58pm, Friday, 27'th Oct 2023
Eli Lilly and Co (NYSE:LLY) is scheduled to report earnings before the market opens on Thursday, with analysts expecting revenue growth but an earnings decline. The drugmaker is expected to post a t
Eli Lilly bowel disease drug approved in US
03:52am, Friday, 27'th Oct 2023
Eli Lilly and Co (NYSE:LLY) has announced that its Omvoh drug has been approved by the US Food and Drug Administration to treat types of inflammatory bowel disease. Following a third-phase 12-week cli
Will Eli Lilly Stock Be Worth More Than Tesla Stock by 2030?
09:05am, Thursday, 26'th Oct 2023
Eli Lilly has the potential to be a huge name in weight loss by the end of the decade. Tesla has significant potential in the electric vehicle market, but it could face a lot of competition.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 24'th Oct 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
03:47pm, Monday, 23'rd Oct 2023
Citi notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative.
Eli Lilly Is Waiting for Obesity-Drug Approval. Here's How Much It Could Be Worth.
08:19am, Monday, 23'rd Oct 2023
Eli Lilly's diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It could drive sales for more than a decade.
Eli Lilly, Novo Nordisk to test weight loss drugs for children
11:00am, Sunday, 22'nd Oct 2023
Pharmaceutical manufacturers Eli Lilly (LLY) and Novo Nordisk (NVO) are reportedly planning to test their weight loss drugs for children six and older. Yahoo Finance Health Reporter Anjalee Khemlani d
Pharma firms testing weight loss drugs for kids amid Ozempic craze
05:12pm, Friday, 20'th Oct 2023
Get ready for Ozem-kids! The pharmaceutical companies behind Ozempic, Mounjaro and Wegovy — which have exploded in popularity with adults looking to lose weight — are testing whether the drugs are
Drugmakers test weigh-loss shots for kids as young as 6
03:30pm, Friday, 20'th Oct 2023
Former FDA commissioner Dr. Scott Gottlieb joins 'Power Lunch' to discuss the latest weight loss headlines.
Eli Lilly planning diabetes drug trial for children six years and older: report
01:01pm, Friday, 20'th Oct 2023
Eli Lilly and Co (NYSE:LLY) is planning a trial of its diabetes drug Mounjaro in patients with obesity as young as six years old according to a Bloomberg report Friday citing a person familiar with t
DGRO: Can Dividends Generate Alpha?
11:40am, Friday, 20'th Oct 2023
DGRO: Can Dividends Generate Alpha?
Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement
10:00am, Friday, 20'th Oct 2023
INDIANAPOLIS , Oct. 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2023 financial results on Thursday, Nov. 2, 2023. Lilly will also conduct a conference ca
Eli Lilly plans diabetes drug trial for kids as young as 6 years - Bloomberg
06:35am, Friday, 20'th Oct 2023
Eli Lilly is planning a clinical trial of its diabetes drug Mounjaro in patients six years and older who have obesity, Bloomberg News reported on Friday, citing a person familiar with the matter.
Hundreds of online sellers are offering an Eli Lilly weight-loss drug that's years away from regulatory approval: WSJ
06:24am, Friday, 20'th Oct 2023
Hundreds of online sellers are offering Eli Lilly' & Co.'s LLY, -2.71% retatrutide weight-loss drug for sale, even though the drug is years away from gaining regulatory approval, the Wall Street Journ
Eli Lilly sues online pharmacies to ban US imports of fake Mounjaro
04:58pm, Thursday, 19'th Oct 2023
Eli Lilly on Thursday said it sued 11 online pharmacies to stop them from importing, selling and distributing products claiming to contain the active ingredient in its diabetes drug Mounjaro, which is
